Liru He

1.0k total citations
54 papers, 758 citations indexed

About

Liru He is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Liru He has authored 54 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Liru He's work include Renal cell carcinoma treatment (13 papers), Esophageal Cancer Research and Treatment (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Liru He is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Esophageal Cancer Research and Treatment (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Liru He collaborates with scholars based in China, United States and Hong Kong. Liru He's co-authors include Binkui Li, Dan Xie, Xin‐Yuan Guan, Yi‐Xin Zeng, Meng‐Zhong Liu, Xiu‐Wu Bian, Zhesheng Wen, Xun Cao, Meng‐Zhong Liu and Pei Dong and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Liru He

51 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liru He China 18 410 263 197 162 159 54 758
Zizhen Feng China 12 671 1.6× 140 0.5× 145 0.7× 137 0.8× 272 1.7× 23 1.0k
Ghassan Allo Canada 16 334 0.8× 172 0.7× 227 1.2× 107 0.7× 194 1.2× 29 796
David Molkentine United States 16 371 0.9× 186 0.7× 125 0.6× 60 0.4× 357 2.2× 30 708
Amanda Eustace United Kingdom 10 290 0.7× 173 0.7× 317 1.6× 93 0.6× 119 0.7× 11 713
Ilse J. Hoogsteen Netherlands 15 337 0.8× 144 0.5× 428 2.2× 57 0.4× 217 1.4× 16 781
Prakash Peddi United States 13 201 0.5× 129 0.5× 125 0.6× 94 0.6× 282 1.8× 33 560
Yasir Y. Elamin United States 16 284 0.7× 518 2.0× 164 0.8× 127 0.8× 595 3.7× 68 968
Vincent J. Bakanauskas United States 8 685 1.7× 230 0.9× 219 1.1× 58 0.4× 428 2.7× 8 975
Hao Hu China 13 151 0.4× 176 0.7× 100 0.5× 58 0.4× 244 1.5× 43 545
Chuanben Chen China 14 158 0.4× 176 0.7× 74 0.4× 103 0.6× 235 1.5× 61 539

Countries citing papers authored by Liru He

Since Specialization
Citations

This map shows the geographic impact of Liru He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liru He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liru He more than expected).

Fields of papers citing papers by Liru He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liru He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liru He. The network helps show where Liru He may publish in the future.

Co-authorship network of co-authors of Liru He

This figure shows the co-authorship network connecting the top 25 collaborators of Liru He. A scholar is included among the top collaborators of Liru He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liru He. Liru He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Lingling, Xinyue Zhang, Ruiqi Liu, et al.. (2025). Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma. Radiotherapy and Oncology. 206. 110802–110802. 1 indexed citations
2.
He, Mengxue, et al.. (2025). Impact of bladder volume and bladder shape on radiotherapy consistency and treatment interruption in prostate cancer patients. Journal of Applied Clinical Medical Physics. 26(4). e70026–e70026.
3.
Huang, Tingxuan, Yulu Peng, Ruiqi Liu, et al.. (2024). Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy. International Immunopharmacology. 142(Pt B). 113106–113106. 3 indexed citations
4.
Liu, Ruiqi, Yilin Li, Xinyue Zhang, et al.. (2023). Fe/Ni layered double hydroxide biocatalysts inhibit tumor growth through ROS and ferroptosis signaling pathway. Chemical Engineering Journal. 466. 142962–142962. 19 indexed citations
5.
Huang, Tingxuan, Jun Wang, Ruiqi Liu, et al.. (2023). Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study. Clinical Genitourinary Cancer. 22(2). 252–260.e3. 2 indexed citations
6.
Wang, Xiaonan, Long Qian, Xiaodi Li, et al.. (2023). The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma. Clinical Epigenetics. 15(1). 14–14. 9 indexed citations
7.
Liu, Yang, Xinyue Zhang, Li Tian, et al.. (2022). Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities. Cancer Medicine. 11(23). 4430–4439. 6 indexed citations
8.
Li, Yilin, Rongliang Zheng, Yijun Zhang, et al.. (2022). Special issue “The advance of solid tumor research in China”: 68Ga‐PSMA‐11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma. International Journal of Cancer. 152(1). 42–50. 17 indexed citations
9.
Dong, Pei, Yulu Peng, Ruiqi Liu, et al.. (2022). Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clinical Cancer Research. 28(21). 4807–4819. 12 indexed citations
10.
Liu, Yang, Zhiling Zhang, Ruiqi Liu, et al.. (2021). Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma. Radiation Oncology. 16(1). 211–211. 12 indexed citations
11.
Liu, Yang, Zhiling Zhang, Zitong Zhang, et al.. (2021). Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy. World Journal of Urology. 39(11). 4183–4190. 19 indexed citations
12.
Zhang, Zitong, Yonghong Li, Ruiqi Liu, et al.. (2020). Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer. Frontiers in Oncology. 10. 606133–606133. 2 indexed citations
13.
Li, Yonghong, Ping Yang, Zitong Zhang, et al.. (2020). Successful management of prostate cancer with bulky pelvic lymph node metastases after rapid development of castration-resistant prostate cancer: a case report with review of the literature. Translational Andrology and Urology. 9(3). 1428–1436. 3 indexed citations
14.
Zhang, Zitong, Yonghong Li, Jian Wu, et al.. (2020). Survival Outcomes and Prognostic Analysis Following Greater Cytoreductive Radiotherapy in Patients With Metastatic Prostate Cancer. Frontiers in Oncology. 10. 549220–549220.
15.
Li, Binkui, Liru He, Dinglan Zuo, et al.. (2017). Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. Journal of Cancer. 8(6). 940–949. 37 indexed citations
16.
Liao, Zhiwei, Lei Zhao, Muyan Cai, et al.. (2016). P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line. Oncology Letters. 13(2). 763–769. 17 indexed citations
17.
Milton, Denái R., Liru He, Ritsuko Komaki, et al.. (2015). Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-esophageal Junction Carcinomas. Journal of Thoracic Oncology. 10(3). 518–526. 4 indexed citations
18.
He, Liru, Pamela K. Allen, Jingya Wang, et al.. (2014). Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology. 9(9). 1398–1405. 46 indexed citations
19.
20.
Cao, Xun, Yujing Han, Liru He, Jin Xiang, & Zhesheng Wen. (2011). Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: Who will benefit from combined treatment?. Oral Oncology. 47(8). 747–752. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zizhen Feng Breakdown of academic impact, for papers by Ghassan Allo Breakdown of academic impact, for papers by David Molkentine Breakdown of academic impact, for papers by Amanda Eustace Breakdown of academic impact, for papers by Ilse J. Hoogsteen Breakdown of academic impact, for papers by Prakash Peddi Breakdown of academic impact, for papers by Yasir Y. Elamin Breakdown of academic impact, for papers by Vincent J. Bakanauskas Breakdown of academic impact, for papers by Hao Hu Breakdown of academic impact, for papers by Chuanben Chen
Rankless by CCL
2026